Capstone DC

Capstone believes that while continued scrutiny by the Food and Drug Administration (FDA) has ended large-scale GLP-1 compounding, non-GLP-1 product categories are unlikely to face targeted enforcement. Products such as peptides and hormone therapies are

The Alternative for Germany (AfD), a far-right party, achieved historic gains in two state elections in September and is seeking to form Germany's first far-right-led state government since World War II. This has raised concerns over the outlook for the r

Capstone believes the Stop Corporate Takeovers of Physicians Act, the first corporate practice of medicine (CPOM) legislation at the federal level, marks a departure from CPOM's history as a state-regulated matter. The bill is based on Oregon's SB 951, a

UK utilities have faced intense public scrutiny in recent years due to outdated infrastructure, repeated environmental failures, and rising consumer bills. Utilities have, as a result, become highly politicised, with their private ownership status increas

The second Trump administration is deeply supporting technology in healthcare, including in asking questions about how artificial intelligence (AI) could revolutionize trials. In clinical trials, the tech-forward shift began during the COVID-19 pandemic,

As the 2026 elections approach, the data center industry has faced increasing scrutiny from elected officials and candidates for public office at all levels of government and across the political spectrum. Investors should be watching closely, as the resu

Capstone believes demand for cybersecurity advisory firms will continue to grow despite the US Department of Defense's (DOD) suspension of the third-party audit mandate for defense contractors, given pressures to comply with underlying security standards.